Raleigh Capital Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15
Closed -$1.79K 714
2025
Q1
$1.79K Sell
15
-27
-64% -$3.35K ﹤0.01% 415
2024
Q4
$4.87K Buy
42
+10
+31% +$1.26K ﹤0.01% 713
2024
Q3
$4.32K Buy
32
+21
+191% +$2.81K ﹤0.01% 717
2024
Q2
$1.49K Hold
11
﹤0.01% 810
2024
Q1
$1.42K Buy
11
+6
+120% +$725 ﹤0.01% 806
2023
Q4
$572 Buy
+5
New +$499 ﹤0.01% 984
2022
Q4
Sell
-12
Closed -$1K 901
2022
Q3
$1K Hold
12
﹤0.01% 790
2022
Q2
$1K Hold
12
﹤0.01% 598
2022
Q1
$1K Hold
12
﹤0.01% 588
2021
Q4
$1K Buy
+12
New +$1.49K ﹤0.01% 301

Other funds holding XYL

Raleigh Capital Management's XYL Position: Q2 2025 in Review

Raleigh Capital Management sold out of Xylem (XYL) in Q2 2025, closing a stake of 15 shares — an estimated $1.79K sold.

Raleigh Capital Management first reported a position in XYL in Q4 2021 and held it in 10 quarters. The position peaked at $4.87K in Q4 2024. 1,063 funds tracked by Wall St. Rank hold XYL as of Q2 2025.

  • Raleigh Capital Management reported no remaining Xylem position as of Q2 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 15 Xylem shares in Q2 2025, an estimated $1.79K.
  • Raleigh Capital Management first reported a position in Xylem in Q4 2021 and held it in 10 quarters.
  • Raleigh Capital Management's Xylem position peaked at $4.87K in Q4 2024.
  • 1,063 funds tracked by Wall St. Rank held Xylem as of Q2 2025.

Based on Raleigh Capital Management's 13F filing for Q2 2025, filed 17 Jul 2025.